Gland Pharma''s result should be good considering below new, even thought it is bit old but worth to take into account. China’s regulatory authority accepts Fosun Pharma clinical trial application of mRNA vaccine candidate (https://www.fosunpharma.com/en/news/news-details-3818.html)
Aniket ji, Dipti buyback also follow TCS path, market price only Rs 10-12 less than buyback price. Moreover Dividend meeting scheduled on 14 January. This is 75th year of Wipro
One of the best performance after IPO listing of year 2020. A portfolio stock, next Divis in pharma injectable sectors. I am still keeping Divis labs in my portfolio purchased @607.
Anchors institutional shareholders usually never sell shares of a company with more than 40% above IPO price. They want price appreciation and Gland pharma is giving them that opportunity.
Gland Pharma Block of 30 L shares available with Brokers clusters in Mumbai. They along with Company are in talks with FII or DII for Selling IPO allotees at 2250 Rs per Piece.
Rajkot Brokers Association
554.1. rsk| Link| Bookmark|
November 26, 2020 11:49:20 AM
IPO Mentor (600+ Posts, 300+ Likes)
Thoda Yudhisthir jaisa bat karen. Bazar mei 2100 par mil raha hai. aaj tak koi block/bulk deal nahi dekhi. FIIs normally buy on first day as there is huge volume available. At current EPS seems fairly valued, unless there are new drivers.